S1 Diabetes, retina, vision : Diabetic retinopathy: out of sight, out of mind |
16:00~17:30 / Thursday 11 October Convention hall C Chairman: Ho Sang Shon, Kyu Jeung Ahn |
Overview |
---|---|---|
Organizers: Nan Hee Kim, Jaetaek Kim This session entitled with 'Diabetes, retina, vision' is translational session and designed to provide a place for clinicians and basic researchers to understand the novel mechanisms and potential therapeutic areas for diabetic retinopathy. Clinical ophthalmology and basic research have complimentarily accumulated invaluable information of drug discovery for diabetic retinopathy. In this session, invited speakers will present the utility of experimental mouse retinal models, and the perspectives on new drugs targeting vascular signals. |
||
|
S1-1 A new approach to retinal vascular diseases | |
|
S1-2 Novel target for diabetic chorioretinopathy | |
|
S1-3 Sustained inflammation and fibrosis in pericyte-deficient retina | |
|
Nan Hee Kim (Korea University, Korea) Jaetaek Kim (Chung-Ang University, Korea) |
S4 Diabetes, cognition : Beyond old paradigm : diabetes-associated cognitive dysfunction |
09:00~10:40 / Friday 12 October Convention hall C Chairman: Jae Myung Yu, Adam R. Wende |
Overview |
---|---|---|
Organizers: Nan Hee Kim, Jaetaek Kim This session entitled with 'Diabetes, cognition' is translational session and designed to provide a place for clinicians and basic researchers to understand the novel mechanisms and potential therapeutic areas for diabetic cognitive dysfunction. Although microvascular and macrovascular complications of diabetes are well recognized, there is a lack of awareness regarding other complications such as cognitive dysfunction, and dementia. In this session, invited speakers will explain the interconnecting link between diabetes and cognitive dysfunction. This session will be the important step toward better understanding the cognitive dysfunction in diabetes. |
||
|
S4-1 Connections between diabetes and cognitive dysfunction | |
|
S4-2 Neuroprotective effect of inulin signaling defect | |
|
S4-3
Neuroprotective effect of insulin signaling
![]() |
|
|
Nan Hee Kim (Korea University, Korea) Jaetaek Kim (Chung-Ang University, Korea) |
S9 Diabetes, epigenetics, complications : Epigenetics: cutting-edge research - application to diabetic complications |
13:20~15:20 / Friday 12 October Convention hall C Chairman: Byung-Joon Kim, Melanie Cree-Green |
Overview |
---|---|---|
Organizers: Nan Hee Kim, Jae Taek Kim This session entitled with 'Diabetes, epigenetics, complications' is translational session and designed to provide a place for clinicians and basic researchers to understand epigenetics of diabetic complications. Epigenetic modifications are one of the most important means for the temporal and spatial control of gene activity. Many studies indicate that specific epigenetic events contribute to programming for the development and progression of diabetic complications. The invited speakers will present their recent works successfully using these strategies to identify novel mechanisms influencing diabetic complications. |
||
|
S9-1
Lipid and ROS-induced mechanisms for diabetic cardiomyopathy
![]() |
|
|
S9-2 Study of noncoding RNAs in vascular smooth muscle cells | |
|
S9-3 Urinary proteome analysis for biomarker discovery to predict renal function decline of diabetic nephropathy | |
|
Sang Soo Kim (Pusan National University, Korea) Kyu-Sang Park (Yonsei University, Korea) Chan Bae Park (Ajou University, Korea) |
S15 Diabetes, microvascular, complications : Three tough questions that are difficult to answer. |
09:00~11:00 / Saturday 13 October Convention hall C Chairman: Yong-Wook Cho, E. Dale Abel |
Overview |
---|---|---|
Organizers: Nan Hee Kim, Jae Taek Kim This session entitled with 'Diabetes, microvascular, complications' is translational session and designed to provide a place for clinicians and basic researchers to understand the important pathophysiologic mechanisms of diabetic microvascular complications. Although there has been a big improvement in the treatment and prognosis of diabetic kidney disease (DKD), there remains an unmet need for innovative treatment. The invited speakers will present the overview of recent preclinical and clinical studies of DKD and the connections between diabetic vascular complications, which demonstrate new insights to outline directions with respect to novel therapies. |
||
|
S15-1 Acute kidney injury: mechanism of AKI sensitivity in diabetic nephropathy | |
|
S15-2
Long journey to overcome diabetic kidney disease. Where are we?
![]() |
|
|
S15-3 Therapeutic application of in vivo genome editing for diabetic retinopathy |
S18 Diabetic neuropathy : All that diabetic neuropathy |
14:30~16:30 / Saturday 13 October Convention hall C Chairman: Kyung Wan Min, Yu-Bae Ahn |
Overview |
---|---|---|
Organizer: Chong Hwa Kim This session entitled with 'Diabetic neuropathy' is translational session and designed to provide a place for clinicians and basic researchers to understand the novel pathophysiologies and potential therapeutic areas for diabetic neuropathy in patient with diabetes. In this session, overview of cardiovascular autonomic neuropathy, pathogenesis of diabetic neuropathy from Schwann cell and in diabetes and a new hope of therapeutic agents in diabetic peripheral neuropathy, will be presented and discussed. This session will be provide the better understanding of pathophysiology and managemt of diabetic neuropathy included diabetic peripheral neuropathy and cardiac autonomic neuropathy. |
||
|
S18-1 Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management | |
|
S18-2 Pathogenesis of diabetic neuropathy from the point of view of schwann cell abnormalities | |
|
S18-3
New hope in management of diabetic peripheral neuropathy
![]() |
|
|
Eun Young Lee (The Catholic University of Korea, Korea) Jae Seung Yun (The Catholic University of Korea, Korea) Chong Hwa Kim (Sejong general hospital, Korea) |